Kynos successfully completes initial phase of drug trials

Kynos Therapeutics has successfully completed the first tests in humans of its leading drug candidate to reduce tissue damage caused by inflammation

Related Keywords

Edinburgh ,City Of ,United Kingdom , ,Ip Group ,University Of Edinburgh ,Damian Mole ,Epidarex Capital ,Scottish Enterprise ,Innovate United ,